Winter 2023 Newsletter

Read the Winter 2023 Newsletter to learn more about the history and importance of African American participation in clinical research. You will also find articles on the importance of taking care of your five senses, study results showing how bilingualism and music may reduce the risk of dementia, helpful resources, and news about upcoming events. Learn more by clicking the link below. Volume 4, Issue 1: Winter 2023

 

 

Seasons Greetings!

The NC Registry for Brain Health team would like to wish you and your family a joyous holiday season!

 

We are grateful you have chosen to be a part of the Registry. By working together, we can improve brain health and defeat dementia.

Sincerely,
The NC Registry for Brain Health team

 

 

Fall 2022 Newsletter

The Fall 2022 Newsletter commemorates National Alzheimer’s Disease Awareness Month and National Native American Heritage Month. Read about a common surgical complication called delirium, upcoming events, and helpful resources. Learn more by clicking the link below. Volume 3, Issue 4: Fall 2022

NC Registry for Brain Health Fall 2022 Newsletter

Summer 2022 Newsletter

The Summer 2022 Newsletter features updates from the July Alzheimer’s Association International Conference (AAIC), news on recent research studies, upcoming events, and tools you can use. Learn more by clicking the link below.

Volume 3, Issue 3: Summer 2022

NC Registry for Brain Health Summer 2022 Newsletter

Spring 2022 Newsletter

Our Spring 2022 newsletter commemorates Older Americans Month. Learn more about healthy aging and the connection to Alzheimer’s and dementia. Get tips on how to stay healthy as you age, news about upcoming events, and helpful resources. Read more by clicking the link below.

Volume 3, Issue 2: Spring 2022

NC Registry for Brain Health Spring 2022 Newsletter

Fall 2021 Newsletter

In honor of National Diabetes Month, the Fall 2021 Newsletter is chock full of information on managing diabetes to help sustain brain health. Get news about Alzheimer’s.gov which is now available in Spanish, learn about upcoming events, and find helpful tools and resources. Read more by clicking the link below.

Vol. 2, Issue 4: Fall 2021

NC Registry for Brain Health Fall 2021 Newsletter

Summer 2021 Newsletter

Read the Summer 2021 Newsletter to get updates on the Alzheimer’s Association International Conference, news about research on pollution and brain conditions, upcoming events, and tools you can use. Learn more by clicking the link below.

Volume 2, Issue 3: Summer 2021

NC Registry for Brain Health Summer 2021 Newsletter

Follow Your Heart

November is National Diabetes Month in the United States. Many people don’t know that having diabetes can put your brain health at risk. Diabetes can damage blood vessels, which results in reduced or blocked blood flow to the brain. This can increase your risks for Alzheimer’s disease, memory loss, and confusion.

The Centers for Disease Control (CDC) has useful tips and resources to help manage blood sugar and protect your brain health. Many resources, including the flyer Healthy Blood Sugar, Healthy Brain, are available in both English and Spanish versions.

 

Language Performance as a Predictor of Future Alzheimer’s Disease

Language sample analysis may help predict future Alzheimer’s disease in people who are cognitively normal, suggesting that language patterns may be an early, detectable biomarker for the disease. Published in EClinicalMedicine, researchers at IBM Thomas J. Watson Research Center and Pfizer Worldwide Research and Development analyzed written language samples and were able to predict Alzheimer’s disease more than seven years before the diagnosis.

Read more

FDA Approves Aduhelm, First Targeted Alzheimer’s Therapy

For the first time in almost 18 years, the U.S. Food and Drug Administration (FDA) has approved a new treatment — Aduhelm, also known as aducanumab — for Alzheimer’s disease, and a first targeted treatment for patients. With this approval, Aduhelm becomes the first disease-modifying therapy for Alzheimer’s, and the first such therapy to come under FDA review.

Read more